ReviewPharmacotherapy2025
Disease-modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications.
Erika L Hellenbart et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it